Research projects

Clinical Trials and Therapeutics
Use of antisense oligonucleotide in Progressive supranuclear palsy
Phase 1 clinical trial funded by Novartis

Phase 1 first in human clinical trial in patients with progressive supranuclear palsy.

Read more

Dr Boyd Ghosh Consultant Neurologist

Related projects:

Using electronic patient records to examine patient outcomes in Dementia with Lewy bodies

Dementia with Lewy bodies (DLB) is the second most common neurodegenerative cause of dementia. However, people with DLB often experience missed or delayed diagnosis. The Clinical Record Interactive Search (CRIS) system allows research and service …

Combining Memantine and Cholinesterase inhibitors in Lewy body dementia treatment trial (COBALT)

Dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD) are two neurodegenerative cause of dementia, in which patients are generally treated with Cholinesterase inhibitors. This is an NIHR Health Technology Assessment funded international multi-centre …

Phase 1 trial of bepranemab in progressive supranuclear palsy

Phase 1 trial of bepranemab in progressive supranuclear palsy

Treating impulsivity in people with progressive supranuclear palsy

Phase 2/3 clinical trial investigating the use of Atomoxetine to treat impulsivity